Fig. 6

(a) Mean percentage of fetal and developmental (f/d) myosin positive fibres at baseline and 48-week time points for all patients. (b) Percentage of f/d myosin positive fibres at baseline and 48 weeks for each patient. (c) Percentage f/d positive myofibres at baseline and 48 weeks for all 25 patients. Baseline sample from patient 22 was excluded due to the biopsy being unsuitable for automated digital analysis. (d)  % change in f/d myosin positive fibres from baseline to 48 weeks for each patient